Promotion Agreement In Japan With Sumitomo Pharma For Izcargo I.V. Infusion 10 Mg
06/04/2023 08:04
April 6 (Reuters) - Sumitomo Pharma Co Ltd 4506.T :
* JCR PHARMACEUTICALS CO LTD - ENTERS INTO CO-PROMOTION
AGREEMENT
IN JAPAN WITH SUMITOMO PHARMA FOR IZCARGO I.V. INFUSION 10 MG
Source text for Eikon: ID:nTSpf84bb1
Further company coverage: 4506.T
(Reporting by Elaine Lies)
((elaine.lies@thomsonreuters.com;))
Recent news on JCR Pharmaceuticals
See all newsBrief: JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo
Italfarmaco And Jcr Pharmaceuticals Enter Into Exclusive License Agreement For Jr-141 In United States, Europe, And Latin America
Brief: Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
Brief: Medipal & JCR Dose First Patient In Global Phase I/II Trial OF JR-446 For Mucopolysaccharidosis Type IIIB
Table: Jcr Pharmaceuticals -Q1 group results